Antimicrobial treatment of asymptomatic bacteriuria in noncatheterized adults

A systematic review

Ryan B. Dull, Stacey K. Friedman, Zara M. Risoldi, Eric C. Rice, Richard C. Starlin, Christopher J. Destache

Research output: Contribution to journalReview article

17 Citations (Scopus)

Abstract

Asymptomatic bacteriuria (ASB) is a common clinical finding characterized by the presence of bacteria in the urine of an individual without signs or symptoms suggestive of urinary tract infection. Despite available guidelines on the diagnosis and management of ASB, it is often managed inappropriately. We performed a systematic review of clinical trials evaluating antimicrobial therapy for ASB, identified translational barriers to evidence-based practice, and we offer strategies to optimize antimicrobial use for ASB. We conducted a systematic search of the PubMed, International Pharmaceutical Abstracts, Cumulative Index to Nursing and Allied Health databases, and the Cochrane Library. Randomized controlled trials, cohort trials, case-control studies, and meta-analyses published in the English language were included in this review if they addressed treatment of ASB with at least one antimicrobial agent in nonpregnant adults. Articles were excluded if they evaluated patients with indwelling urinary catheters or were not clinical trials. Of the 304 articles identified from the search, 287 were excluded; thus 17 articles met the inclusion criteria. Although treatment of ASB with antimicrobial therapy may improve short-term microbiologic outcomes, the clinical significance is diminished because the effect is not sustained, there is no measurable improvement in morbidity or mortality, and some data indicate that therapy is deleterious. Several translational barriers that preclude adoption of evidence-based practice are identified. Treatment guidelines may not achieve their desired effect and underscore the need for additional methods to translate clinical trial data into practice. Clinical pharmacists are a core member of the antimicrobial stewardship team and in an important position to participate in initiatives that promote appropriate antimicrobial use. We suggest a multifaceted approach consisting of education and frequent routine prospective audits with feedback coupled with appropriate process and outcome measures.

Original languageEnglish
Pages (from-to)941-960
Number of pages20
JournalPharmacotherapy
Volume34
Issue number9
DOIs
StatePublished - 2014

Fingerprint

Bacteriuria
Evidence-Based Practice
Clinical Trials
Therapeutics
Guidelines
Urinary Catheters
Indwelling Catheters
Process Assessment (Health Care)
Anti-Infective Agents
Pharmacists
PubMed
Urinary Tract Infections
Libraries
Signs and Symptoms
Meta-Analysis
Case-Control Studies
Nursing
Language
Randomized Controlled Trials
Outcome Assessment (Health Care)

All Science Journal Classification (ASJC) codes

  • Pharmacology (medical)
  • Medicine(all)

Cite this

Antimicrobial treatment of asymptomatic bacteriuria in noncatheterized adults : A systematic review. / Dull, Ryan B.; Friedman, Stacey K.; Risoldi, Zara M.; Rice, Eric C.; Starlin, Richard C.; Destache, Christopher J.

In: Pharmacotherapy, Vol. 34, No. 9, 2014, p. 941-960.

Research output: Contribution to journalReview article

Dull, Ryan B. ; Friedman, Stacey K. ; Risoldi, Zara M. ; Rice, Eric C. ; Starlin, Richard C. ; Destache, Christopher J. / Antimicrobial treatment of asymptomatic bacteriuria in noncatheterized adults : A systematic review. In: Pharmacotherapy. 2014 ; Vol. 34, No. 9. pp. 941-960.
@article{55fd5be5b53c40f0aa9b8e9d27e0481a,
title = "Antimicrobial treatment of asymptomatic bacteriuria in noncatheterized adults: A systematic review",
abstract = "Asymptomatic bacteriuria (ASB) is a common clinical finding characterized by the presence of bacteria in the urine of an individual without signs or symptoms suggestive of urinary tract infection. Despite available guidelines on the diagnosis and management of ASB, it is often managed inappropriately. We performed a systematic review of clinical trials evaluating antimicrobial therapy for ASB, identified translational barriers to evidence-based practice, and we offer strategies to optimize antimicrobial use for ASB. We conducted a systematic search of the PubMed, International Pharmaceutical Abstracts, Cumulative Index to Nursing and Allied Health databases, and the Cochrane Library. Randomized controlled trials, cohort trials, case-control studies, and meta-analyses published in the English language were included in this review if they addressed treatment of ASB with at least one antimicrobial agent in nonpregnant adults. Articles were excluded if they evaluated patients with indwelling urinary catheters or were not clinical trials. Of the 304 articles identified from the search, 287 were excluded; thus 17 articles met the inclusion criteria. Although treatment of ASB with antimicrobial therapy may improve short-term microbiologic outcomes, the clinical significance is diminished because the effect is not sustained, there is no measurable improvement in morbidity or mortality, and some data indicate that therapy is deleterious. Several translational barriers that preclude adoption of evidence-based practice are identified. Treatment guidelines may not achieve their desired effect and underscore the need for additional methods to translate clinical trial data into practice. Clinical pharmacists are a core member of the antimicrobial stewardship team and in an important position to participate in initiatives that promote appropriate antimicrobial use. We suggest a multifaceted approach consisting of education and frequent routine prospective audits with feedback coupled with appropriate process and outcome measures.",
author = "Dull, {Ryan B.} and Friedman, {Stacey K.} and Risoldi, {Zara M.} and Rice, {Eric C.} and Starlin, {Richard C.} and Destache, {Christopher J.}",
year = "2014",
doi = "10.1002/phar.1437",
language = "English",
volume = "34",
pages = "941--960",
journal = "Pharmacotherapy",
issn = "0277-0008",
publisher = "Pharmacotherapy Publications Inc.",
number = "9",

}

TY - JOUR

T1 - Antimicrobial treatment of asymptomatic bacteriuria in noncatheterized adults

T2 - A systematic review

AU - Dull, Ryan B.

AU - Friedman, Stacey K.

AU - Risoldi, Zara M.

AU - Rice, Eric C.

AU - Starlin, Richard C.

AU - Destache, Christopher J.

PY - 2014

Y1 - 2014

N2 - Asymptomatic bacteriuria (ASB) is a common clinical finding characterized by the presence of bacteria in the urine of an individual without signs or symptoms suggestive of urinary tract infection. Despite available guidelines on the diagnosis and management of ASB, it is often managed inappropriately. We performed a systematic review of clinical trials evaluating antimicrobial therapy for ASB, identified translational barriers to evidence-based practice, and we offer strategies to optimize antimicrobial use for ASB. We conducted a systematic search of the PubMed, International Pharmaceutical Abstracts, Cumulative Index to Nursing and Allied Health databases, and the Cochrane Library. Randomized controlled trials, cohort trials, case-control studies, and meta-analyses published in the English language were included in this review if they addressed treatment of ASB with at least one antimicrobial agent in nonpregnant adults. Articles were excluded if they evaluated patients with indwelling urinary catheters or were not clinical trials. Of the 304 articles identified from the search, 287 were excluded; thus 17 articles met the inclusion criteria. Although treatment of ASB with antimicrobial therapy may improve short-term microbiologic outcomes, the clinical significance is diminished because the effect is not sustained, there is no measurable improvement in morbidity or mortality, and some data indicate that therapy is deleterious. Several translational barriers that preclude adoption of evidence-based practice are identified. Treatment guidelines may not achieve their desired effect and underscore the need for additional methods to translate clinical trial data into practice. Clinical pharmacists are a core member of the antimicrobial stewardship team and in an important position to participate in initiatives that promote appropriate antimicrobial use. We suggest a multifaceted approach consisting of education and frequent routine prospective audits with feedback coupled with appropriate process and outcome measures.

AB - Asymptomatic bacteriuria (ASB) is a common clinical finding characterized by the presence of bacteria in the urine of an individual without signs or symptoms suggestive of urinary tract infection. Despite available guidelines on the diagnosis and management of ASB, it is often managed inappropriately. We performed a systematic review of clinical trials evaluating antimicrobial therapy for ASB, identified translational barriers to evidence-based practice, and we offer strategies to optimize antimicrobial use for ASB. We conducted a systematic search of the PubMed, International Pharmaceutical Abstracts, Cumulative Index to Nursing and Allied Health databases, and the Cochrane Library. Randomized controlled trials, cohort trials, case-control studies, and meta-analyses published in the English language were included in this review if they addressed treatment of ASB with at least one antimicrobial agent in nonpregnant adults. Articles were excluded if they evaluated patients with indwelling urinary catheters or were not clinical trials. Of the 304 articles identified from the search, 287 were excluded; thus 17 articles met the inclusion criteria. Although treatment of ASB with antimicrobial therapy may improve short-term microbiologic outcomes, the clinical significance is diminished because the effect is not sustained, there is no measurable improvement in morbidity or mortality, and some data indicate that therapy is deleterious. Several translational barriers that preclude adoption of evidence-based practice are identified. Treatment guidelines may not achieve their desired effect and underscore the need for additional methods to translate clinical trial data into practice. Clinical pharmacists are a core member of the antimicrobial stewardship team and in an important position to participate in initiatives that promote appropriate antimicrobial use. We suggest a multifaceted approach consisting of education and frequent routine prospective audits with feedback coupled with appropriate process and outcome measures.

UR - http://www.scopus.com/inward/record.url?scp=84906887054&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84906887054&partnerID=8YFLogxK

U2 - 10.1002/phar.1437

DO - 10.1002/phar.1437

M3 - Review article

VL - 34

SP - 941

EP - 960

JO - Pharmacotherapy

JF - Pharmacotherapy

SN - 0277-0008

IS - 9

ER -